Working… Menu
Trial record 1 of 1 for:    PHast-TSC
Previous Study | Return to List | Next Study

Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke (PHAST-TSC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03763929
Recruitment Status : Terminated (The study was stopped due to lack of meaningful enrollment due to the COVID-19 pandemic.)
First Posted : December 4, 2018
Last Update Posted : December 17, 2020
University of California, Los Angeles
University of Virginia
Information provided by (Responsible Party):
Diffusion Pharmaceuticals Inc

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : October 19, 2020
Actual Study Completion Date : October 19, 2020